Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Purvi Prajapati

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Surgical Endoscopy|May 29, 2020
The role of preoperative workup in predicting dysphagia, dilation, or explantation after magnetic sphincter augmentationSteven G Leeds, Ahmed Ebrahim, Eric M Potter, et al.
The Journal of Trauma and Acute Care Surgery|March 22, 2017
Traumatic colon injury in damage control laparotomy-A multicenter trial: Is it safe to do a delayed anastomosis?Leah Carey Tatebe, Andrew Jennings, Ken Tatebe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 28, 2026
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical TrialJoseph F Merola, Philip Mease, Alan Kivitz, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Surgical Endoscopy|May 29, 2020
The role of preoperative workup in predicting dysphagia, dilation, or explantation after magnetic sphincter augmentationSteven G Leeds, Ahmed Ebrahim, Eric M Potter, et al.
The Journal of Trauma and Acute Care Surgery|March 22, 2017
Traumatic colon injury in damage control laparotomy-A multicenter trial: Is it safe to do a delayed anastomosis?Leah Carey Tatebe, Andrew Jennings, Ken Tatebe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 28, 2026
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical TrialJoseph F Merola, Philip Mease, Alan Kivitz, et al.
Pageof 2